Clinical Trials | July 10, 2025
82% of people prefer diagnostic centers over hospitals for preventive checkups in India
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
The study showed that sClever-1 is released by macrophages and blood vessel cells and binds to activated T cells
Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy
The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma
A triple-action Formula for comprehensive respiratory relief
ISG acknowledged Indegene's strengths in implementing holistic creative workflows, interoperability via robust integration with tech ecosystems
Capstan's lead asset, CPTX2309, is a targeted lipid nanoparticle (tLNP) that delivers an mRNA encoding an anti-CD19 chimeric antigen receptor (CAR) to CD8-expressing cytotoxic T cells in vivo
Subscribe To Our Newsletter & Stay Updated
